Hypercoagulable states in arterial and venous thrombosis: When, how, and who to test?

Vasc Med. 2018 Aug;23(4):388-399. doi: 10.1177/1358863X18755927.

Abstract

Evaluation for underlying hypercoagulable states in patients with thrombosis is a frequent clinical conundrum. Testing for thrombophilias is often reflexively performed without strategic approach nor clear appreciation of the clinical implications of such results. Guidelines vary in the appropriate utilization of thrombophilia testing. In this review, we discuss the more commonly encountered inherited and acquired thrombophilias, their association with initial and recurrent venous thromboembolism, arterial thromboembolism, and role in women's health. We suggest an approach to thrombophilia testing guided by the clinical presentation, suspected pathophysiology, and an understanding of how such results may affect patient care.

Keywords: arterial thrombosis; hypercoagulable states; thrombophilia; venous thromboembolism (VTE).

Publication types

  • Review

MeSH terms

  • Aged
  • Anticoagulants / administration & dosage
  • Arterial Occlusive Diseases / blood
  • Arterial Occlusive Diseases / diagnosis*
  • Arterial Occlusive Diseases / drug therapy
  • Arterial Occlusive Diseases / genetics
  • Blood Coagulation Tests*
  • Blood Coagulation* / drug effects
  • Blood Coagulation* / genetics
  • Clinical Decision-Making
  • Female
  • Genetic Predisposition to Disease
  • Humans
  • Male
  • Middle Aged
  • Patient Selection
  • Phenotype
  • Predictive Value of Tests
  • Prognosis
  • Recurrence
  • Thrombophilia / blood
  • Thrombophilia / diagnosis*
  • Thrombophilia / drug therapy
  • Thrombophilia / genetics
  • Thrombosis / blood
  • Thrombosis / diagnosis*
  • Thrombosis / drug therapy
  • Thrombosis / genetics
  • Venous Thrombosis / blood
  • Venous Thrombosis / diagnosis*
  • Venous Thrombosis / drug therapy
  • Venous Thrombosis / genetics
  • Young Adult

Substances

  • Anticoagulants